Jonathan Arnon

6PUBLICATIONS
13CO-AUTHORS
Radiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 27, 2025
RapidPlan Knowledge-Based Radiotherapy Planning Compared to Manual Planning in Locally Advanced Non-Small-Cell Lung Cancer.

Tal Falick Michaeli, Tamar Abu Said, Stanislav Raskin

|Jul 15, 2025
Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Ori Aslan, Johnathan Arnon, Itamar Averbuch

|Mar 17, 2025
Real-World Data on Osimertinib-Associated Cardiac Toxicity.

Abed Agbarya, Ari Raphael, Hadas Gantz Sorotsky

|Jan 12, 2025
Predictive value of ENLIGHT-DP in patients with metastatic lung adenocarcinoma treated with immune checkpoint inhibitors and platinum chemotherapy directly from histopathology slides using inferred transcriptomics.

Johnathan Arnon, Gal Dinstag, Omer Tirosh

|Oct 14, 2023
Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.

Johnathan Arnon, Michael Tabi, Yakir Rottenberg

|Aug 11, 2022
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center's 20 years of Experience.

Johnathan Arnon, Simona Grozinsky-Glasberg, Kira Oleinikov

Pageof 1

Frequent Collaborators

2 joint publications

Philip Blumenfeld

1 joint publications

Amichay Meirovitz

1 joint publications

Aviad Zick

1 joint publications

Eli Pikarsky